C4 Therapeutics Inc banner

C4 Therapeutics Inc
NASDAQ:CCCC

Watchlist Manager
C4 Therapeutics Inc Logo
C4 Therapeutics Inc
NASDAQ:CCCC
Watchlist
Price: 3.12 USD -13.09% Market Closed
Market Cap: $302.4m

Wall Street
Price Targets

CCCC Price Targets Summary
C4 Therapeutics Inc

Wall Street analysts forecast CCCC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CCCC is 11.51 USD with a low forecast of 5.05 USD and a high forecast of 31.5 USD.

Lowest
Price Target
5.05 USD
62% Upside
Average
Price Target
11.51 USD
269% Upside
Highest
Price Target
31.5 USD
910% Upside
C4 Therapeutics Inc Competitors:
Price Targets
OFIX
Orthofix Medical Inc
48% Upside
PTEN
Patterson-UTI Energy Inc
-6% Downside
JACK
Jack in the Box Inc
60% Upside
MEDP
Medpace Holdings Inc
7% Upside

Revenue
Forecast

9% / Year
Past Growth
-6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
9% / Year
Past Growth
-6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 6 years the compound annual growth rate for C4 Therapeutics Inc's revenue is 9%. The projected CAGR for the next 3 years is -6%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-50%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-50%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CCCC's stock price target?
Price Target
11.51 USD

According to Wall Street analysts, the average 1-year price target for CCCC is 11.51 USD with a low forecast of 5.05 USD and a high forecast of 31.5 USD.

What is C4 Therapeutics Inc's Revenue forecast?
Projected CAGR
-6%

For the last 6 years the compound annual growth rate for C4 Therapeutics Inc's revenue is 9%. The projected CAGR for the next 3 years is -6%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett